Biotechnologies news and biotechnologies widget

ALAMEDA, Calif.----BioTime, Inc. Chief Executive Officer Michael West, Ph.D. delivered the keynote presentation on Wednesday, november 19, at a meeting in Madison, Wisconsin commemorating the 10th anniversary of the publication describing the first derivation and culturing of human embryonic stem cells.

CAMBRIDGE, Mass.----Targanta Therapeutics Corporation today announced that oritavancin, the Companyâ??s investigational antibiotic therapy for the treatment of complicated skin and skin structure infections caused by gram-positive pathogens, including methicillin resistant Staphylococcus aureus , received a mixed review from the United States Food and Drug Administrationâ??s Anti-Infective Drugs Advisory Committee.

Biotech drugmaker Amgen Inc. and a unit of Japanese drugmaker Takeda Pharmaceutical Co. suspended enrollment in a late-stage trial of a cancer drug after patients on the drug died more often than those on placebo.

[NEWS] SAN FRANCISCO, Nov. 19 /PRNewswire/ — Posit Science Corporation researcher, Dan Tinker, presented evidence at the Society for Neuroscience Annual Conference in Washington, DC this week indicating that cognitive training may benefit Baby Boomers. The computerized brain plasticity-based Brain Fitness Program ™ uses adaptive exercises that target auditory and language systems. The exercises are designed to drive generalized improvements in cognition by improving speed and accuracy of information proce…

[NEWS] LAUSANNE, Switzerland and BANGALORE, India, november 20 /PRNewswire/ — Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre-IND drug candidates, signed an exclusive worldwide license agreem…

Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96.

ST. LOUIS, MO (MARKET WIRE) Cachexia has emerged as a high-profile, high-potential-value supportive care indication in the oncology market and is potentially the most competitive and lucrative indication for the first novel agent approved, according to a physician study conducted by The Mattson Jack Group, Inc. (MattsonJack), a recognized leader in business analytics for the pharmaceutical and healthcare industries.

[NEWS] SACRAMENTO, Calif., Nov. 20 — The oversight board of California's stem cell agency should be reduced to 15 and new members representing the general public interest must be included, consumer Watchdog said today. In addition, the agency's grant review process must be opened to public scrutiny.   The recommendations came in testimony by Consumer Watchdog's John Simpson, Director of the group's Stem Cell Project, at the request of the Little Hoover Commission, the sta…

[NEWS] International Agreement Licenses Seno's Opto-Acoustic Imaging technology To VisualSonics to Enable Molecular Imaging at the Cellular Level and Aid in the Pursuit of Neurology, Regenerative Medicine, Inflammation, and Cancer Applications   TORONTO and SAN ANTONIO, TX, Nov. 20 /PRNewswire/ - VisualSonics and Seno Medical Instruments today announced the official signing of a licensing agreement providing VisualSonics exclusive rights to Sen…

RED BLUFF, CA (MARKET WIRE) A live surgical webcast of MAKOplasty(R) robotic arm partial knee resurfacing will be presented by Thomas M. Coon, M.D. and St. Elizabeth Community Hospital on December 1st at 3:00 p.m. PST. MAKOplasty(R) is a new, minimally invasive partial knee resurfacing procedure used to treat early to mid-stage knee osteoarthritis that offers a more precise and consistent result that can provide relief.